Caregen Co.Ltd Total Liabilities

Latest as of June 2025: ₩17.10 Billion KRW ≈ $11.59 Million USD

Caregen Co.Ltd total liabilities. Based on the latest financial reports, Caregen Co.Ltd (214370) has total liabilities worth ₩17.10 Billion KRW (≈ $11.59 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of Caregen Co.Ltd to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Caregen Co.Ltd (2015–2024)

Total liabilities of Caregen Co.Ltd from 2015 to 2024. This chart illustrates how Caregen Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Caregen Co.Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

Caregen Co.Ltd Competitors by Total Liabilities

The table below lists competitors of Caregen Co.Ltd ranked by their total liabilities.

Company Country Total Liabilities
Bulten AB
ST:BULTEN
Sweden Skr2.68 Billion
Muramoto Electron (Thailand) Public Company Limited
BK:METCO
Thailand ฿2.81 Billion
Newbury Street II Acquisition Corp Class A Ordinary Shares
NASDAQ:NTWO
USA $6.16 Million
Universal Microelectronics Co Ltd
TW:2413
Taiwan NT$2.43 Billion
Eco Atlantic Oil & Gas Ltd
V:EOG
Canada CA$1.26 Million
NINtec Systems Limited
NSE:NINSYS
India Rs527.45 Million
Kobay Tech Bhd
KLSE:6971
Malaysia RM255.47 Million

Liability Composition Analysis (2015–2024)

This chart breaks down Caregen Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 214370 current and non-current assets.

Liquidity & Leverage Metrics

Caregen Co.Ltd Total Liabilities Ratios Explained

Caregen Co.Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 13.01 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.08 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.07 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Caregen Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Caregen Co.Ltd (2015–2024)

The table below shows the annual total liabilities of Caregen Co.Ltd from 2015 to 2024.

Year Total Liabilities Change
2024-12-31 ₩17.72 Billion
≈ $12.01 Million
-11.31%
2023-12-31 ₩19.98 Billion
≈ $13.54 Million
+10.43%
2022-12-31 ₩18.09 Billion
≈ $12.26 Million
+6.16%
2021-12-31 ₩17.04 Billion
≈ $11.55 Million
+49.55%
2020-12-31 ₩11.40 Billion
≈ $7.72 Million
-23.20%
2019-12-31 ₩14.84 Billion
≈ $10.06 Million
+4.61%
2018-12-31 ₩14.18 Billion
≈ $9.61 Million
-6.65%
2017-12-31 ₩15.19 Billion
≈ $10.30 Million
+1.14%
2016-12-31 ₩15.02 Billion
≈ $10.18 Million
+96.52%
2015-12-31 ₩7.65 Billion
≈ $5.18 Million
--

About Caregen Co.Ltd

KQ:214370 Korea Pharmaceuticals
Market Cap
$196.57 Million
₩290.06 Billion KRW
Market Cap Rank
#16408 Global
#600 in Korea
Share Price
₩27000.00
Change (1 day)
-2.35%
52-Week Range
₩27000.00 - ₩150100.00
All Time High
₩150100.00
About

Caregen Co., Ltd. engages in the research, development, and commercialization of biomimetic peptides and growth factors worldwide. The company offers cosmeceutical products and food supplements under the Dermaheal, Renokin, Deglusterol, PURILUX, Pelo Baum, Pim-Pim-Paul, Neovert, and PTx brands. It also provides medical devices under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG S… Read more